Vitruvia Medical : In order to gain a valid impression of the companies' operating performance, boersengefluester.de (BGFL) has summarised the key figures in table form. Where individual figures are still estimates, they are taken from BGFL.
| The most important financial data at a glance | ||||||||||
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | |
| Sales1 | 0,00 | 0,00 | 0,00 | 0,00 | 5,60 | 1,97 | 1,42 | 1,75 | 0,00 | 0,00 |
| EBITDA1,2 | 0,00 | 0,00 | 0,00 | 0,00 | -0,96 | -0,75 | -0,91 | 0,06 | 0,00 | 0,00 |
| EBITDA-Margin3 | 0,00 | 0,00 | 0,00 | 0,00 | -17,14 | -38,07 | -64,09 | 3,43 | 0,00 | 0,00 |
| EBIT1,4 | 0,00 | 0,00 | 0,00 | 0,00 | -1,31 | -7,69 | -1,24 | -0,37 | 0,00 | 0,00 |
| EBIT-Margin5 | 0,00 | 0,00 | 0,00 | 0,00 | -23,39 | -390,36 | -87,32 | -21,14 | 0,00 | 0,00 |
| Net Profit (Loss)1 | 0,00 | 0,00 | 0,00 | 0,00 | -1,54 | -7,71 | -1,48 | -0,54 | 0,00 | 0,00 |
| Net-Margin6 | 0,00 | 0,00 | 0,00 | 0,00 | -27,50 | -391,37 | -104,23 | -30,86 | 0,00 | 0,00 |
| Cashflow1,7 | 0,00 | 0,00 | 0,00 | 0,00 | -0,21 | -0,78 | -0,67 | -0,10 | 0,00 | 0,00 |
| Earnings per share8 | 0,00 | 0,00 | 0,00 | 0,00 | -0,85 | -4,19 | -0,59 | -0,21 | -0,09 | -0,08 |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: BDO
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
